Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 24 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0032991 | protein-containing complex | 1 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HDZ2
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 16 |
GO:0003723 | RNA binding | 4 | 16 |
GO:0005488 | binding | 1 | 16 |
GO:0097159 | organic cyclic compound binding | 2 | 16 |
GO:1901363 | heterocyclic compound binding | 2 | 16 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003730 | mRNA 3'-UTR binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.351 |
CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.351 |
DOC_CYCLIN_RxL_1 | 43 | 50 | PF00134 | 0.551 |
DOC_MAPK_gen_1 | 98 | 104 | PF00069 | 0.551 |
DOC_PP4_MxPP_1 | 5 | 8 | PF00568 | 0.663 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.713 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.480 |
LIG_FHA_2 | 36 | 42 | PF00498 | 0.551 |
LIG_IBAR_NPY_1 | 144 | 146 | PF08397 | 0.653 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.542 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.537 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.592 |
LIG_SH2_NCK_1 | 115 | 119 | PF00017 | 0.577 |
LIG_SH2_STAT3 | 146 | 149 | PF00017 | 0.603 |
LIG_SH2_STAT3 | 158 | 161 | PF00017 | 0.742 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.632 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.771 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.551 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.551 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.673 |
MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.759 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.339 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.659 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.623 |
MOD_NEK2_2 | 54 | 59 | PF00069 | 0.514 |
MOD_PIKK_1 | 13 | 19 | PF00454 | 0.700 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.544 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.587 |
TRG_ER_diArg_1 | 111 | 114 | PF00400 | 0.580 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.351 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P4G4 | Trypanosomatidae | 66% | 81% |
A0A1X0P4M7 | Trypanosomatidae | 67% | 97% |
A0A3Q8ID53 | Leishmania donovani | 87% | 100% |
A0A3S7WYY4 | Leishmania donovani | 91% | 100% |
A0A422NWY7 | Trypanosoma rangeli | 69% | 100% |
A4HDZ1 | Leishmania braziliensis | 100% | 100% |
A4I191 | Leishmania infantum | 87% | 100% |
D0A986 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 78% |
E9AH94 | Leishmania infantum | 90% | 73% |
E9AXC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 97% |
E9AXC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4QA45 | Leishmania major | 86% | 100% |
Q4QA46 | Leishmania major | 90% | 100% |
V5BNA6 | Trypanosoma cruzi | 69% | 100% |